{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:21:50Z","timestamp":1770434510144,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ejca.2009.04.002","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T09:07:56Z","timestamp":1241514476000},"page":"2116-2122","source":"Crossref","is-referenced-by-count":26,"title":["Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours"],"prefix":"10.1016","volume":"45","author":[{"given":"C.","family":"Sessa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cresta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Noberasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Capri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gallerani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. De","family":"Braud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"D\u2019Incalci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Corradino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Minoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zintl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejca.2009.04.002_bib1","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1200\/JCO.2005.09.032","article-title":"Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails","volume":"23","author":"Sessa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2009.04.002_bib2","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1073\/pnas.97.12.6780","article-title":"Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743","volume":"97","author":"Minuzzo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.ejca.2009.04.002_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1124\/mol.105.013615","article-title":"Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters","volume":"68","author":"Minuzzo","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.ejca.2009.04.002_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ijc.1221","article-title":"Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways","volume":"92","author":"Damia","year":"2001","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2009.04.002_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ejca.2008.01.003","article-title":"Role of homologous recombination in trabectedin-induced DNA damage","volume":"44","author":"Tavecchio","year":"2008","journal-title":"Eur J Cancer"},{"issue":"32","key":"10.1016\/j.ejca.2009.04.002_bib6","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1073\/pnas.0609877104","article-title":"Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743","volume":"104","author":"Soares","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.ejca.2009.04.002_bib7","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.ejca.2007.05.003","article-title":"Targeting DNA repair as a promising approach in cancer therapy","volume":"43","author":"Damia","year":"2007","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.ejca.2009.04.002_bib8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0959-8049(03)00490-8","article-title":"The combination of yondelis and cisplatin is synergistic against human tumor xenografts","volume":"39","author":"D\u2019Incalci","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.04.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2008.11.019","article-title":"Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer","author":"Sessa","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2009.04.002_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bjc.6600062","article-title":"Weekly platinum chemotherapy for recurrent ovarian cancer","volume":"86","author":"Clamp","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2009.04.002_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.04.002_bib12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/(SICI)1096-9888(1998110)33:11<1134::AID-JMS730>3.0.CO;2-S","article-title":"Quantitative determination of ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry","volume":"33","author":"Rosing","year":"1998","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.ejca.2009.04.002_bib13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0959-8049(03)00458-1","article-title":"Phase I and pharmacokinetic study of Yondelis (ecteinascidin-743; ET-743) administered as an infusion over 1h or 3h every 21 days in patients with solid tumours","volume":"39","author":"Twelves","year":"2003","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2009.04.002_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00280-008-0733-7","article-title":"Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors","volume":"63","author":"Messersmith","year":"2008","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909002512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909002512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T04:52:57Z","timestamp":1545281577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804909002512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0959804909002512"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2009.04.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}